These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9727165)

  • 1. [Program of empirical antibacterial therapy of community-acquired pneumonia].
    Suvorova MP; Iakovlev SV; Shakhova TV; Dvoretskiĭ LI
    Antibiot Khimioter; 1998; 43(7):31-5. PubMed ID: 9727165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Stepwise therapy of community-acquired pneumonia. Results of cefuroxime and cefuroxime axetil study].
    Iakovlev SV; Suvorova MP; Dvoretskiĭ LI; Vlasenko NA; Shakhova TV
    Antibiot Khimioter; 1998; 43(6):7-11. PubMed ID: 9644527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The usefulness of sputum gram stain and culture.
    Musher DM
    Arch Intern Med; 2005 Feb; 165(4):470-1. PubMed ID: 15738381
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical effect of gatifloxacin, 200 mg daily, on bacterial community-acquired pneumonia in the elderly.
    Okimoto N; Kibayashi T; Mimura K; Yamato K; Kurihara T; Honda Y; Osaki K; Asaoka N; Ohba H
    J Infect Chemother; 2005 Dec; 11(6):274-7. PubMed ID: 16369733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Coamoxiclav in the empirical monotherapy in outpatients with community acquired pneumonia].
    Yakovlev SV; Leshchenko IV; Kolesnikov VV; Suvorova MP
    Antibiot Khimioter; 1997; 42(10):19-22. PubMed ID: 9412398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefuroxime compared to amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.
    Oh HM; Ng AW; Lee SK
    Singapore Med J; 1996 Jun; 37(3):255-7. PubMed ID: 8942221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and ambulatory treatment of patients with community-acquired pneumonia: variability of complementary tests and study of the effectiveness of roxithromycin. Study Group on Ambulatory Treatment of Community-Acquired Pneumonia (NACTA)].
    Rev Clin Esp; 1999 Nov; 199(11):700-4. PubMed ID: 10638232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prospective and comparative study between cefuroxime, ceftriaxone and amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia].
    Sánchez ME; Gómez J; Gómez Vargas J; Baños V; Ruiz Gómez J; Muñoz L; Simarro E; Soto MC; Canteras M; Valdés M
    Rev Esp Quimioter; 1998 Jun; 11(2):132-8. PubMed ID: 9795298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is azithromycin monotherapy as efficacious as cefuroxime plus erythromycin for the treatment of community-acquired pneumonia in hospitalized patients?
    See S
    J Fam Pract; 2000 Oct; 49(10):883-4. PubMed ID: 11052155
    [No Abstract]   [Full Text] [Related]  

  • 10. [Enhancing efficacy of the primary antibacterial therapy for intraabdominal infections].
    Boĭko VV; Ivanova IuV
    Klin Khir; 2012 Nov; (11):54-8. PubMed ID: 23272388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is gentamicin safe and effective for severe community-acquired pneumonia? An 8-year retrospective cohort study.
    Brereton CJ; Lennon D; Browning S; Dunn E; Ferguson JK; Davis JS
    Int J Antimicrob Agents; 2018 Jun; 51(6):862-866. PubMed ID: 29410326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of lower respiratory tract infections in elderly].
    Iakovlev SV
    Ter Arkh; 1997; 69(12):57-63. PubMed ID: 9503539
    [No Abstract]   [Full Text] [Related]  

  • 13. [Achromobacter xylosoxidans bacteremia in a patient with community-acquired pneumonia].
    de Fernández MI; Bugarín G; Arévalo CE
    Medicina (B Aires); 2001; 61(1):79-80. PubMed ID: 11265630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of efficacy and safety of josamycin (Vilprafen) in the treatment of patients with community-acquired pneumonia].
    Iakovlev SV; Aleksandrova MA; Suvorova MP; Kostina SA
    Antibiot Khimioter; 2006; 51(3-4):47-8, 50-2. PubMed ID: 17165259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia.
    Kollef MH; Vlasnik J; Sharpless L; Pasque C; Murphy D; Fraser V
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1040-8. PubMed ID: 9351601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical use of cefuroxime in paediatric community-acquired pneumonia.
    Olivier C
    Paediatr Drugs; 2000; 2(5):331-43. PubMed ID: 11022795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
    Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
    J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan.
    Lee SC; Huang SS; Lee CW; Fung CP; Lee N; Shieh WB; Siu LK
    BMC Infect Dis; 2007 Jul; 7():79. PubMed ID: 17640342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High variability among Emergency Departments in 3rd-generation cephalosporins and fluoroquinolones use for community-acquired pneumonia.
    Batard E; Lecadet N; Goffinet N; Hardouin JB; ; Lepelletier D; Potel G; Montassier E
    Infection; 2015 Dec; 43(6):681-9. PubMed ID: 25998004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The choice of antibacterial drugs.
    Med Lett Drugs Ther; 1998 Mar; 40(1023):33-42. PubMed ID: 9549552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.